MNKD Q3 2017 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-98.7% YoY

Gross Profit

-$3M-123.9% margin

Operating Income

-$28M-1379.3% margin

Net Income

-$33M-1609.7% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-5.5%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$56M

Total Liabilities

$307M

Stockholders' Equity

-$251M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$162M	-98.7%
Gross Profit	-$3M	$135M	-101.9%
Operating Income	-$28M	$118M	-123.8%
Net Income	-$33M	$127M	-126.0%

Revenue Segments

Product

$900,000100%